It has been demonstrated earlier that patients with COVID-19 shifted towards a cytotoxic phenotype in the T cell compartment, as indicated by high degranulation capacity (granzyme B and perforin levels) compared to healthy controls [2]. This evidence concerns the gene GZMB and COVID-19.